Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Amazon.com, Inc. (AMZN) -- Ignore unavailable to you. Want to Upgrade?

To: Robert Rose who wrote (96344)	3/14/2000 12:29:00 PM
From: H James Morris	Read Replies (1) \| Respond to of 164684

>I'd look at it as a buying opp except that I'm on margin. OUCH!!!!!! Robert, sorry to hear that.:-( But being on margin in volatile times can be risky. What ever you do don't get a fed call! That's the kiss of death.

To: Robert Rose who wrote (96344)	3/14/2000 1:28:00 PM
From: Libbyt	Respond to of 164684

Biotech... >Sam, thanks for your take on biotech.< I agree with the thoughts that Sam posted....mainly about "spread your bets, and that biotech does not move in internet time" The market's reaction to the "news" from Clinton and Blair is a total overreaction. This "news" is nothing that hasn't already been stated in the past. Clinton may want this to happen, but the government can not make it happen. (Going back in history, some of the same thoughts were voiced about Genetic when it first began.) The nature of the field of medicine is to help those in need. The tradition of medicine is to share data to help humanity. (The reason the Human Genome Project was first established...a worldwide project, not an American project...and established before any of these biotech companies really became known, was to share data to help humanity.) The researchers of the world who work in traditional medicine want to have this information available so that everyone will benefit. However, nothing has changed...and the "news" today is not saying anything that hasn't been said before, and nothing basically has changed with any of these companies. I just returned from Palm Springs where there was a meeting of the American College of Medical Genetics. There were several companies that were being discussed "off the record" who were developing a "black name" with other academic based researchers, for the way they were obtaining their information and research. Some of these companies are going against the basic traditions of research and medicine, and are considered unethical in their methods. (But again...this is nothing new!) Hopefully these stocks will come back strongly in price as others see this as a buying opportunity. Libbyt